In the Nordics we produce high quality alcohol beverages. Spirits we are utterly proud of.  Now it's due for someone to blend these products with cow's milk, add classic Nordic berries and fruits, and create a whole new series of Premium Cream Liqueurs for the International market.  In contrary to Irish cream which is based on whiskey, the Nordic Cream are going to be based on traditional Nordic spirits, like the aquavit. In a typical Fjording Nordic Cream recipe you'll find aquavit/vodka/fruit spirits, cream, honey/sugar or other sweetening, and then juice from berries and fruits from the Nordic fauna. Not just aromas and concentrates - the real deal. It shall be as local, genuine and organic as possible. Except from the sugar we'll be looking for the ingredients in our nearby surroundings.

Aprex is a Norwegian software company from Tønsberg that builds practical AI systems, automation, integrations and custom software for Nordic businesses with manual, operational workflows. Many companies still run on spreadsheets, copy and paste between systems, and tools that look great in a demo but fall apart on a busy Monday morning. We fix that one workflow at a time. We map the data, roles and risk, build a narrow first version, and test it with real users before anything is scaled. A typical pilot takes 2 to 6 weeks. What we build: AI solutions (internal copilots, RAG, AI agents and document flow), automation, integrations, custom software, mobile apps and websites. Aprex was founded in 2026 by Preben Skatvedt Ruud and Alexander Terje Loe Balsnes. We are a small team, and you always talk to the people who design, build and run the software.

Tenol is developing a structured recruitment platform to help young candidates and local businesses solve the gap between first-job seekers and relevant entry-level job opportunities through practical matching, candidate screening and a clearer recruitment process. Many young people struggle to get their first job, not necessarily because they lack motivation, but because the path into work is unclear. They often do not know where to start, how to present themselves, or how to become visible to employers. At the same time, many businesses need motivated people for full- or part-time roles, extra help, weekend shifts and practical tasks, but do not always have the time or structure to find and assess young candidates properly. This creates a gap between young people who want to work and businesses that need help. Tenol is focused on making that connection easier, safer and more structured. Tenol helps candidates register their interest, availability and profile in a structured way. Businesses can describe their needs, such as role, working hours, requirements and preferred candidate profile. Tenol then works to match candidates with relevant opportunities based on practical fit, including availability, motivation, role requirements and communication. Instead of only forwarding names, Tenol aims to provide businesses with clearer candidate shortlists and structured candidate presentations. The goal is to reduce friction for businesses while giving young candidates a more professional and understandable path into working life. The motivation behind Tenol comes from seeing how difficult the first step into working life can be for many young people. A lot of candidates are motivated, but they are not always given a clear or fair way to show it. At the same time, businesses often need reliable help, but the process of finding young candidates can be time-consuming and unstructured. Tenol was started because this connection can be better. First jobs matter. They build confidence, experience, responsibility and future opportunities. Tenol exists to make that first connection between candidate and employer more practical, structured and human.

Vexter hjelper B2B-selgere å jobbe smartere ved å kombinere presis prospektdata med et intelligent AI-verktøy for e-post outreach. Vi gjør det enkelt å finne riktige leads, bygge målrettede kampanjer og skape flere møter på kortere tid. Med Vexter bruker du mindre tid på manuelle prosesser og mer tid på å selge. Plattformen omsetter data til innsikt som øker konverteringsraten, øker effektiviteten og skalerer veksten.

Asenti uses AI to review construction project documents and detect errors, inconsistencies, and missing information before they cause problems on site. By improving quality control early in the process, we help construction teams reduce costly mistakes, avoid rework, and improve coordination across disciplines.

Vi samler Norges skarpeste IT-juniorer på én plass, for å levere syke teknologiske løsninger innen AI, Data Science og systemutvikling til våre kunder. Vi har tro på at kompetanse måles på hva du får til, ikke hvor mange års erfaring du har, så hos oss er de fleste konsulentene fremdeles studenter som jobber deltid. Kunder som Hydro, Helsedir og Digdir hyrer ikke oss fordi det er "modig" eller "spennende" å bruke ungt talent, men fordi det er megalønnsomt.

We help brands navigate spoken media. Every day we capture and analyze thousands of podcasts, TikTok videos, YouTube videos, and news feeds to find the conversations that really matter for your business. We find insights that are impossible to find with traditional media monitoring and insights tools.

The building industry alone accounts for 40% of the global CO2 emissions. We believe that reducing this number starts with looking at materials we already have. Reuse of building materials is however not easy to coordinate and execute. Our mission is therefore to make this information available, and facilitate the process from design to construction. Through a series of web-applications and integrations with Building Information Modelling (BIM) software, we’ve started to form synchronized and comprehensive solutions to help the building industry reduce its climate change. Tvinn Solutions Enables Circular Economy through Reuse-oriented Solutions for rchitects, Real-estate developers and owners.

We enable the green shift to happen in new markets! TioTech is a Norwegian producer of titania (TiO2) nanomaterials and a developer of titania-based technology. We know how to optimise the production process and properties of titania nanoparticles. After successfully developing and commercialising a series of photocatalytic surface treatment products (www.joma-int.com), we are directing our R&D efforts towards a new area; the use of titania as anode-material in Lithium-ion batteries (LIB). A battery with our material on the anode will charge faster, last longer, be safer and tolerate temperature variation better than conventional batteries which have graphite on the anode, and outcompete LTO-batteries on capacity. The development work takes place in our in-house laboratory in Bergen, where our dedicated team (Hjørdis, Marthe, Rob, Anders) play around with titania, giving life to innovative solutions.

Batteries - Made in Norway Concept, design, prototype, production, repairs. ​ Batteries for golf carts, forklifts, e-bikes, small EVs, wheelchairs and more — giving your eVehicles a second life! Battkomp designs produce, and repairs li-ion batteries in the 0.5 to 10 kWh range for mobility applications. Battkomp can produce batteries in any shape or size, complete with housing, safety systems, appropriate connectors, and communication systems to ensure complete compatibility with the host device.​​ 1. Help your product development by providing custom batteries for prototypes 2. Give older battery-driven products a new life by converting from lead acid or NiMH to lithium 3. Provide replacement batteries for products where the OEM is no longer available ​ The battery production services are targeted toward customers who wish to order at least 5-10 batteries.

Cavai AS was founded in December 2017 with the goal of revolutionizing online advertising. User experiences have largely been neglected on the web, and Cavai saw early on that chatbot technology, which has initially been used in customer service, could be a wonderfully good advertising product. Usually, chatbot technology is used as customer service on its own website, while Cavai's platform is built to be able to use chatbot technology on millions of websites for contextual advertising. The team today consists of 15 people, and the product has been launched in Norway, Finland, Sweden and the UK with 50 paying customers. Customers are very pleased and report that Cavai's technology is having a very good effect on completed advertising campaigns. Cavai will have its first month of positive operating results in October and looks to have sales of around 3 million in 2019. Next year will be a big growth year, where we have budgeted with a turnover of NOK 41 million. This growth has also been discussed by Finansavisen, where as part of Finansavisen's web-TV series "Vext", Cavai filmed his meeting with advertising legend Sir Marting Sorell in London. For more information, see https://finansavisen.no/vext/tech/2019/10/23/7465643/chatbot-company-cavai-2020-blir-the-store-growst>  To finance further growth, we are now running a seed funding round of NOK 9.5 - 15 million. The company is priced at NOK 60 million pre-money. For more information see the investor summary, investor presentation and subscription form attached.

Disruptive Engineering enables more effective planning, management, and monitoring of road networks. Proprietary sensor hardware 'made in Norway'Use AI and neural networks for detailed classification of vehicles. Privacy-by-design solution ensuring that no personal data is stored or shared. With traffic expected to grow by 60% by 2050, and with congestion and safety already being an issue, there is a pressing need to utilize road networks more efficiently. Both Statens Vegvesen and Nye Veier see our first sensor VS1, and the valuable data it provides, as a potential solution to achieve this as well as an opportunity to digitalize roads and infrastructure for the forthcoming Intelligent Transportation Systems (ITS) that are being implemented across Europe.Statens Vegvesen linkNye Veier link

Biim is a global medical company developing low-cost portable and pocketable ultrasound devices that connect to IOS and Android interfaces. Biim is entering the commercial stage with both FDA and CE approvals in place. The company has signed a 3-year distr. agreement with AngioDynamics worth a minimum of 20 million USD. Year-to-date revenue has exceeded more than 2.4 million USD. The company has secured a credit facility of 4 million USD with DNB. Biim is raising up to 9 million USD for the development of two new probes and to expand the global footprint to more than 30 countries.

We have developed a system for calculating and supplying Solcelle, and wind power for Scandinavia. In addition to this, we have obtained a license as a power supplier, so we can offer our customers both purchases and sales of green power. Why solar cells? Sun provides energy. As an energy source, the sun is unsurpassed. Every year, the earth receives 15,000 times more energy from the sun than the earth's population uses. Even in Norway, the sun provides 1,500 times more energy than what we use. Depending on where on the globe you are, the sun provides an amount of energy from 700 to over 2,200 kWh/m2 per year.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.